Sanara Medtech Inc reports results for the quarter ended in December - Earnings Summary

Sanara MedTech

26/03/2024 05:23

* Sanara Medtech Inc  SMTI.OQ  reported a quarterly adjusted
loss
of 3 cents​​ per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of -38 cents.  The lone analyst forecast for the quarter was
for a loss of 13 cents per share. 
    * Revenue rose 15.5% to $17.69 million from a year ago;
analysts
expected $16.50 million. 
    * Sanara Medtech Inc's reported EPS for the quarter was a
loss
of 3 cents​.
    * The company reported a quarterly loss of $237.19 thousand.
    * Sanara Medtech Inc shares had fallen by 11.8% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Sanara Medtech
Inc is $49.00 
This summary was machine generated from LSEG data March 26 at
05:23 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.13          -0.03          Beat
 Sep. 30 2023      0.00           -0.13          Missed
 Jun. 30 2023      -0.13          -0.22          Missed
 Mar. 31 2023      -0.33          -0.14          Beat